mevalonic acid has been researched along with Cardiovascular Diseases in 17 studies
*Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Britza, SM; Byard, RW; Farrington, R; Musgrave, IF; Zechner, J | 1 |
| Anderson, KA; Backos, DS; Crown, SB; Grimsrud, PA; Hirschey, MD; Ilkayeva, OR; Kulkarni, RA; Meier, JL; Stevens, RD; Thompson, JW; Trub, AG; Wagner, GR; Zhang, GF | 1 |
| Basson, AK; Dludla, PV; Mabhida, SE; Mazibuko-Mbeje, SE; Mthembu, SXH; Muller, CJF; Nkambule, BB; Nyambuya, TM; Orlando, P; Silvestri, S; Tiano, L; Ziqubu, K | 1 |
| Casal-Dominguez, M; Mammen, AL; Pinal-Fernandez, I | 1 |
| Norata, GD | 1 |
| Ande, SR; Freed, DH; Ghavami, S; Hashemi, M; Moghadam, AR; Post, M; Sharma, P; Shojaei, S; Wiechec, E; Yeganeh, B; Zeki, AA | 1 |
| Ande, SR; Chen, QM; Hashemi, M; Hoshyar, R; Naderi, M; Solomon, C; Zuse, A | 1 |
| Lahtela, J; Murtola, TJ; Syvälä, H; Tammela, TLj; Visakorpi, T | 1 |
| Ishibashi, T | 1 |
| Keizer, HG | 1 |
| DiNicolantonio, JJ | 1 |
| Poirier, J | 1 |
| Laufs, U; Liao, JK | 1 |
| Gotto, AM; Vaughan, CJ | 1 |
| Bravo, L; Gupta, J; McAnally, JA; Mo, H; Sodhani, S | 1 |
| Duleba, AJ; Kodaman, PH | 1 |
| Elson, CE | 1 |
13 review(s) available for mevalonic acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Flavonoid-statin interactions causing myopathy and the possible significance of OATP transport, CYP450 metabolism and mevalonate synthesis.
Topics: Cardiovascular Diseases; Cytochrome P-450 Enzyme System; Drug Interactions; Flavonoids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Mevalonic Acid; Muscular Diseases; Myotoxicity; Organic Anion Transporters; Risk Factors | 2022 |
Impact of dyslipidemia in the development of cardiovascular complications: Delineating the potential therapeutic role of coenzyme Q
Topics: Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Ubiquinone | 2023 |
Statins: pros and cons.
Topics: Anti-Inflammatory Agents; Anticholesteremic Agents; Atherosclerosis; Blood Coagulation; Cardiovascular Diseases; Cerebral Hemorrhage; Cholesterol; Diabetes Mellitus, Type 2; Endothelium, Vascular; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Inflammation; Mevalonic Acid; Musculoskeletal Diseases | 2018 |
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
Topics: Alkyl and Aryl Transferases; Animals; Cardiovascular Diseases; Farnesyltranstransferase; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Diseases; Mevalonic Acid; Neoplasms; Pulmonary Disease, Chronic Obstructive; rho GTP-Binding Proteins; rho-Associated Kinases | 2014 |
Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
Topics: Acyl Coenzyme A; Animals; Cardiovascular Diseases; Cholesterol; GTP Phosphohydrolases; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infections; Mevalonic Acid; Neoplasms; Polyisoprenyl Phosphates; Sesquiterpenes; Signal Transduction | 2017 |
Statins and prostate cancer prevention: where we are now, and future directions.
Topics: Animals; Apoptosis; Cardiovascular Diseases; Cell Cycle; Comorbidity; Disease Progression; GTPase-Activating Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Meta-Analysis as Topic; Mevalonic Acid; Prostate-Specific Antigen; Prostatic Neoplasms; ras GTPase-Activating Proteins | 2008 |
[Anti-atherosclerotic and anti-inflammatory effects of statin on cardiovascular disease and their mechanisms].
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Mevalonic Acid; Monomeric GTP-Binding Proteins; Plaque, Atherosclerotic; Pravastatin; Primary Prevention; Randomized Controlled Trials as Topic; Secondary Prevention | 2011 |
CoQ10 and L-carnitine for statin myalgia?
Topics: Cardiovascular Diseases; Carnitine; Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mitochondria, Muscle; Musculoskeletal Pain; Ubiquinone | 2012 |
Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Brain; Cardiovascular Diseases; Central Nervous System; Cholesterol; Humans; Mevalonic Acid; Models, Biological; Models, Chemical; Phospholipids | 2003 |
Isoprenoid metabolism and the pleiotropic effects of statins.
Topics: Cardiovascular Diseases; Cardiovascular System; Evaluation Studies as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Mevalonic Acid; Polyisoprenyl Phosphates; Time Factors | 2003 |
Update on statins: 2003.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Cholesterol, LDL; Creatine Kinase; Creatine Kinase, MM Form; Drug Interactions; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Inactivation, Metabolic; Isoenzymes; Male; Mevalonic Acid; Middle Aged; Models, Biological; Muscular Diseases; Prospective Studies; Protein Prenylation; Randomized Controlled Trials as Topic; Structure-Activity Relationship | 2004 |
Statins in the treatment of polycystic ovary syndrome.
Topics: Cardiovascular Diseases; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Models, Biological; Ovary; Oxidative Stress; Polycystic Ovary Syndrome; Signal Transduction | 2008 |
Suppression of mevalonate pathway activities by dietary isoprenoids: protective roles in cancer and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Diet; Humans; Hydroxymethylglutaryl-CoA Synthase; Mevalonic Acid; Neoplasms; Neoplasms, Experimental; Terpenes | 1995 |
4 other study(ies) available for mevalonic acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Statin therapy inhibits fatty acid synthase via dynamic protein modifications.
Topics: Cardiovascular Diseases; Cholesterol; Fatty Acid Synthases; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid | 2022 |
Trained immunity and cardiovascular disease: is it time for translation to humans?
Topics: Cardiovascular Diseases; Humans; Immunity, Innate; Mevalonic Acid; Monocytes | 2018 |
The "Mevalonate hypothesis": a cholesterol-independent alternative for the etiology of atherosclerosis.
Topics: Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cholesterol; Free Radicals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Metabolic Networks and Pathways; Mevalonic Acid; Models, Cardiovascular | 2012 |
Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mevalonic Acid; Mice; Neoplasm Proteins; Neoplasms; Terpenes; Tocotrienols | 2007 |